Sanfilippo type A treatment
Scope
Date
~
-
Korean startups
Asleep dreams big to help sleepless people worldwide find right treatment
Armed with artificial intelligence and big data technologies, Asleep hopes to find the best treatment for sleep-deprived people around the world wit...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
AbClon shows promising results in clinical tests of leukemia treatment
South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...
Apr 19, 2023 (Gmt+09:00)
-
Real estate
Specialty income by preferred securities, commercial MBS
With a hamstrung US Federal Reserve, the global outlook for 2023 is one of cautious optimism for fixed income. As the Fed is unable to readily rescu...
Apr 17, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB starts Phase 3 clinical trials for ophthalmic disease treatment in US
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...
Apr 13, 2023 (Gmt+09:00)
-
Korean stock market
VIP Asset’s new mutual fund to forgo operating fees if it posts losses
VIP Asset Management Co., a leading South Korean asset manager, said on Friday it is launching a new mutual fund, and its managers won’t take ...
Mar 31, 2023 (Gmt+09:00)
-
Food & Beverage
S.Korea's exports of instant noodles exceed $800 mn mark in 2022
South Korea's exports of instant noodles such as ramen last year exceeded $800 million to break an all-time record.Export data released on Thursday ...
Mar 30, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hyundai E&C, KAI to develop export-type package for defense industry
South Korea's Hyundai Engineering & Construction (E&C) and Korea Aerospace Industries Ltd. (KAI) will jointly develop an export package for ...
Mar 28, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma receives 1st overseas patent for its hair loss treatment
JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's microneedle maker Raphas to enter US market
South Korea's microneedle maker Raphas Co. is expediting its entry into the American pharmaceutical market after entering the country's cosmetics se...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
PharmaResearch pays employees $7,706 bonus for having 3rd child
With South Korea setting new lows in birth rate every year, PharmaResearch on Wednesday said it will adopt an unprecedented system of childbirth and...
Mar 23, 2023 (Gmt+09:00)
-
Robotics
Doosan Robotics signs medical robot MOU with Chinese company
Doosan Robotics Inc., a South Korean company affiliated with the Doosan Group, announced on Tuesday that it had signed an MOU with Guangxi Pinge, a ...
Mar 21, 2023 (Gmt+09:00)
-
Waste management
Toray Advanced Materials acquires S.Korea's water treatment company
Toray Advanced Materials Korea Inc. announced on Monday the acquisition of Hanmee Entec Co., Ltd., the industry's longest-running water treatment fa...
Mar 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
Mar 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong wins approval for GERD treatment Fexuclu in Chile
South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada
Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...
Mar 06, 2023 (Gmt+09:00)
-
Electronics
LG Elec wins best eco-friendly washing machine title in US
Consumer Reports, a prominent consumer magazine in the US, has named LG Electronics Inc.'s washing machines as the "best eco-friendly washing machin...
Feb 20, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SK Shieldus introduces EDR-specialized control, analysis services
South Korea's IT security service firm SK Shieldus made an announcement on Thursday that they will be providing control and operation, investigation...
Feb 17, 2023 (Gmt+09:00)
-
Bio & Pharma
AIMMED’s Somzz ushers in digital therapeutic device market in Korea
South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Plasma, Janssen Korea sign sales, distribution agreement
SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanall Biopharma invests in Interon Labs for brain disease treatments
South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...
Feb 13, 2023 (Gmt+09:00)
-
Asset management
Samsung Asset Management's bond-type ETF assets exceed $7.9 billion
Investment in South Korea is pouring into bond-type exchange-traded funds (ETFs) under the anticipation that interest rate hikes end this year. Such...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha kickstarts localization of 1,000-hp gas turbine engine components
A project to lengthen the lifecycle of 1,000-horsepower gas turbine engine core components and materials, which is led by Hanwha Aerospace Co. locat...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N to introduce biosimilars for bone disease treatment from Spain
South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand